About this trial
The aim is to investigate whether information and educational initiatives on the Swedish national care pathway for hypertension, directed at primary care centers, lead to an increase in the proportion of patients achieving target blood pressure.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Crossover
Treatments tested in this trial
Educational intervention for doctors and nurses
Other interventionEducational intervention for doctors and nurses. Information and educational initiatives on the national care pathway for hypertension, including specific recommendations regarding treatment and the use of digital support tools. The intervention consists of in-person lectures by a physician educator, combined with an information package for physicians, nurses and patients. This includes standardised treatment algorithms with early combination therapy. Educational material will be made available electronically. Primary care centers will be provided with tools for continuous monitoring of their performance.
Treatment groups
Trial outcomes
Primary outcomes
Change from baseline in the proportion of patients with blood pressure <130/<80 mmHg
Proportion of patients with a diagnosis of hypertension and at least one blood pressure recorded in 6-month intervals whose last recorded blood pressure was below the target according to the person-centered and integrated care pathway (PSVF) for hypertension (\<130/\<80 mmHg), irrespective of measurement method (office, home, or ambulatory blood pressure monitoring). The outcome is assessed in each 6-month interval, and the primary effect measure is the average effect over the first 12 months after each center's scheduled crossover.
Secondary outcomes
Change from baseline in the proportion of patients with their blood pressure measured
Proportion of patients with a diagnosis of hypertension who, in each 6-month interval had their blood pressure measured
Change from baseline in the proportion of patients who were dispensed statin therapy
Proportion of patients with a diagnosis of hypertension who were dispensed statin therapy
Change from baseline in the proportion of patients who achieved an office blood pressure <140/<90 mmHg, a home blood pressure <135/<85 mmHg, or an ambulatory blood pressure <135/<85 mmHg
Proportion of patients with a diagnosis of hypertension and at least one blood pressure recorded in 6-month intervals who achieved an office blood pressure \<140/\<90 mmHg, a home blood pressure \<135/\<85 mmHg, or an ambulatory blood pressure \<135/\<85 mmHg. The outcome is assessed in each 6-month interval, and the effect measure is the average effect over the first 12 months after each center's scheduled crossover.
Change from baseline in the proportion of patients who were dispensed combination therapy with antihypertensive agents
Proportion of patients with a diagnosis of hypertension and at least one blood pressure recorded in the 6-month interval who were dispensed combination therapy with antihypertensive agents (2, 3, or more)
Other outcomes
Adverse drug reactions related to antihypertensive medication
Safety outcome. Adverse drug reactions related to antihypertensive medication: acute kidney injury, hypotension or syncope, orthostatic hypotension, and fall injury. Based on hospitalizations with relevant ICD-10 codes.
Myocardial infarction and stroke
Hypertension-related complications: myocardial infarction and stroke
All-cause mortality
All-cause mortality
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Region Stockholm
Lead sponsor
Karolinska Institutet
Collaborator
This trial is not recruiting at the moment. You can still explore other options: